Build Your Comparison

Side-by-side financial analysis
NGVT logo
NGVT
LIN logo
LIN
JPM logo
JPM
ECL logo
ECL
BAC logo
BAC
Try popular comparisons:

Stock Comparison

NGVT vs LIN vs JPM vs ECL vs BAC

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
NGVT
Ingevity Corporation

Chemicals - Specialty

Basic MaterialsNYSE • US
Market Cap$2.54B
5Y Perf.+36.9%
LIN
Linde plc

Chemicals - Specialty

Basic MaterialsNASDAQ • GB
Market Cap$242.62B
5Y Perf.+146.8%
JPM
JPMorgan Chase & Co.

Banks - Diversified

Financial ServicesNYSE • US
Market Cap$896.00B
5Y Perf.+241.0%
ECL
Ecolab Inc.

Chemicals - Specialty

Basic MaterialsNYSE • US
Market Cap$74.96B
5Y Perf.+33.4%
BAC
Bank of America Corporation

Banks - Diversified

Financial ServicesNYSE • US
Market Cap$422.78B
5Y Perf.+135.9%

NGVT vs LIN vs JPM vs ECL vs BAC — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
NGVT logoNGVT
LIN logoLIN
JPM logoJPM
ECL logoECL
BAC logoBAC
IndustryChemicals - SpecialtyChemicals - SpecialtyBanks - DiversifiedChemicals - SpecialtyBanks - Diversified
Market Cap$2.54B$242.62B$896.00B$74.96B$422.78B
Revenue (TTM)$1.21B$34.66B$280.33B$16.08B$191.57B
Net Income (TTM)$-128M$7.13B$57.05B$2.08B$30.51B
Gross Margin39.3%46.0%60.0%44.5%56.1%
Operating Margin22.8%28.8%25.9%17.7%19.7%
Forward P/E14.6x29.3x14.4x31.9x12.6x
Total Debt$1.24B$26.99B$942.38B$9.43B$365.90B
Cash & Equiv.$78M$5.06B$343.34B$646M$231.84B

NGVT vs LIN vs JPM vs ECL vs BACLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

NGVT
LIN
JPM
ECL
BAC
StockJun 20Jun 26Return
Ingevity Corporation (NGVT)100136.9+36.9%
Linde plc (LIN)100246.8+146.8%
JPMorgan Chase & Co. (JPM)100341.0+241.0%
Ecolab Inc. (ECL)100133.4+33.4%
Bank of America Cor… (BAC)100235.9+135.9%

Price return only. Dividends and distributions are not included.

Quick Verdict: NGVT vs LIN vs JPM vs ECL vs BAC

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: LIN and JPM are tied at the top with 2 categories each (5-stock set) — the right choice depends on your priorities. JPMorgan Chase & Co. is the stronger pick specifically for growth and revenue expansion and valuation and capital efficiency. NGVT, ECL, and BAC also each lead in at least one category. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
NGVT
Ingevity Corporation
The Momentum Pick

NGVT ranks third and is worth considering specifically for momentum.

  • +66.6% vs ECL's -1.0%
Best for: momentum
LIN
Linde plc
The Income Pick

LIN has the current edge in this matchup, primarily because of its strength in income & stability and growth exposure.

  • Dividend streak 34 yrs, beta 0.20, yield 1.1%
  • Rev growth 3.0%, EPS growth 7.1%, 3Y rev CAGR 0.6%
  • Lower volatility, beta 0.20, Low D/E 67.9%, current ratio 0.88x
  • Beta 0.20, yield 1.1%, current ratio 0.88x
Best for: income & stability and growth exposure
JPM
JPMorgan Chase & Co.
The Banking Pick

JPM is the #2 pick in this set and the best alternative if long-term compounding and valuation efficiency is your priority.

  • 465.8% 10Y total return vs LIN's 402.9%
  • PEG 0.81 vs LIN's 1.15
  • NIM 2.2% vs BAC's 1.8%
  • 3.3% NII/revenue growth vs NGVT's -17.0%
Best for: long-term compounding and valuation efficiency
ECL
Ecolab Inc.
The Niche Pick

ECL is the clearest fit if your priority is efficiency.

  • 8.8% ROA vs NGVT's -7.3%, ROIC 12.7% vs 14.2%
Best for: efficiency
BAC
Bank of America Corporation
The Banking Pick

BAC is the clearest fit if your priority is dividends.

  • 2.3% yield, 12-year raise streak, vs ECL's 1.0%, (1 stock pays no dividend)
Best for: dividends
See the full category breakdown
CategoryWinnerWhy
GrowthJPM logoJPM3.3% NII/revenue growth vs NGVT's -17.0%
ValueJPM logoJPMLower P/E (14.4x vs 31.9x)
Quality / MarginsLIN logoLIN20.6% margin vs NGVT's -10.6%
Stability / SafetyLIN logoLINBeta 0.20 vs NGVT's 1.27, lower leverage
DividendsBAC logoBAC2.3% yield, 12-year raise streak, vs ECL's 1.0%, (1 stock pays no dividend)
Momentum (1Y)NGVT logoNGVT+66.6% vs ECL's -1.0%
Efficiency (ROA)ECL logoECL8.8% ROA vs NGVT's -7.3%, ROIC 12.7% vs 14.2%

NGVT vs LIN vs JPM vs ECL vs BAC — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

NGVTIngevity Corporation
FY 2025
Performance Materials
60.2%$607M
Performance Chemicals
39.8%$401M
LINLinde plc
FY 2025
Americas Segment
45.9%$15.2B
EMEA Segment
25.8%$8.5B
APAC Segment
20.1%$6.7B
Engineering Segment
8.2%$2.7B
JPMJPMorgan Chase & Co.
FY 2025
Commercial And Investment Bank
43.0%$78.5B
Consumer & Community Banking
41.7%$76.0B
Asset and Wealth Management Segment
13.2%$24.1B
Segment Reporting, Reconciling Item, Corporate Nonsegment
3.9%$7.0B
Segment Reconciling Items
-1.7%$-3,134,000,000
ECLEcolab Inc.
FY 2025
Global Water
49.6%$8.0B
Global Institutional and Specialty
38.0%$6.1B
Global Pest Elimination
7.8%$1.2B
Global Life Sciences
4.7%$748M
BACBank of America Corporation
FY 2024
Loans and Leases
32.2%$62.0B
other interest income
14.7%$28.3B
Debt securities
13.5%$26.0B
Federal funds sold and securities borrowed or purchased under agreements to resell
10.3%$19.9B
Investment And Brokerage Services
9.2%$17.8B
Market making and similar activities
6.7%$13.0B
Trading account assets
5.4%$10.4B
Other (4)
7.8%$15.1B

NGVT vs LIN vs JPM vs ECL vs BAC — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLNGVTLAGGINGBAC

Income & Cash Flow (Last 12 Months)

LIN leads this category, winning 3 of 6 comparable metrics.

JPM is the larger business by revenue, generating $280.3B annually — 231.4x NGVT's $1.2B. LIN is the more profitable business, keeping 20.6% of every revenue dollar as net income compared to NGVT's -10.6%. On growth, LIN holds the edge at +8.2% YoY revenue growth, suggesting stronger near-term business momentum.

MetricNGVT logoNGVTIngevity Corporat…LIN logoLINLinde plcJPM logoJPMJPMorgan Chase & …ECL logoECLEcolab Inc.BAC logoBACBank of America C…
RevenueTrailing 12 months$1.2B$34.7B$280.3B$16.1B$191.6B
EBITDAEarnings before interest/tax$378M$12.1B$81.4B$3.5B$40.0B
Net IncomeAfter-tax profit-$128M$7.1B$57.0B$2.1B$30.5B
Free Cash FlowCash after capex$246M$5.1B$100.9B$1.9B$12.6B
Gross MarginGross profit ÷ Revenue+39.3%+46.0%+60.0%+44.5%+56.1%
Operating MarginEBIT ÷ Revenue+22.8%+28.8%+25.9%+17.7%+19.7%
Net MarginNet income ÷ Revenue-10.6%+20.6%+20.4%+12.9%+15.9%
FCF MarginFCF ÷ Revenue+20.3%+14.7%+36.0%+11.8%+6.6%
Rev. Growth (YoY)Latest quarter vs prior year-9.2%+8.2%+4.8%
EPS Growth (YoY)Latest quarter vs prior year+196.4%+13.4%+16.0%+19.3%+18.3%
LIN leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

NGVT leads this category, winning 3 of 7 comparable metrics.

At 14.7x trailing earnings, BAC trades at a 60% valuation discount to ECL's 36.5x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 0.90x vs LIN's 1.41x — a lower PEG means you pay less per unit of expected earnings growth.

MetricNGVT logoNGVTIngevity Corporat…LIN logoLINLinde plcJPM logoJPMJPMorgan Chase & …ECL logoECLEcolab Inc.BAC logoBACBank of America C…
Market CapShares × price$2.5B$242.6B$896.0B$75.0B$422.8B
Enterprise ValueMkt cap + debt − cash$3.7B$264.6B$1.50T$83.7B$556.8B
Trailing P/EPrice ÷ TTM EPS-15.61x35.89x16.00x36.46x14.66x
Forward P/EPrice ÷ next-FY EPS est.14.60x29.25x14.40x31.92x12.56x
PEG RatioP/E ÷ EPS growth rate1.41x0.90x0.95x
EV / EBITDAEnterprise value multiple10.05x20.83x18.36x23.36x13.92x
Price / SalesMarket cap ÷ Revenue2.17x7.14x3.20x4.66x2.21x
Price / BookPrice ÷ Book value/share87.73x6.17x2.47x7.72x1.39x
Price / FCFMarket cap ÷ FCF9.27x47.68x8.88x39.36x33.52x
NGVT leads this category, winning 3 of 7 comparable metrics.

Profitability & Efficiency

NGVT leads this category, winning 4 of 9 comparable metrics.

ECL delivers a 22.0% return on equity — every $100 of shareholder capital generates $22 in annual profit, vs $-156 for NGVT. LIN carries lower financial leverage with a 0.68x debt-to-equity ratio, signaling a more conservative balance sheet compared to NGVT's 41.84x. On the Piotroski fundamental quality scale (0–9), BAC scores 7/9 vs ECL's 5/9, reflecting strong financial health.

MetricNGVT logoNGVTIngevity Corporat…LIN logoLINLinde plcJPM logoJPMJPMorgan Chase & …ECL logoECLEcolab Inc.BAC logoBACBank of America C…
ROE (TTM)Return on equity-156.1%+17.8%+15.9%+22.0%+10.1%
ROA (TTM)Return on assets-7.3%+8.3%+1.3%+8.8%+0.9%
ROICReturn on invested capital+14.2%+11.3%+4.5%+12.7%+3.5%
ROCEReturn on capital employed+17.1%+13.0%+8.9%+15.8%+4.5%
Piotroski ScoreFundamental quality 0–966557
Debt / EquityFinancial leverage41.84x0.68x2.60x0.96x1.21x
Net DebtTotal debt minus cash$1.2B$21.9B$599.0B$8.8B$134.1B
Cash & Equiv.Liquid assets$78M$5.1B$343.3B$646M$231.8B
Total DebtShort + long-term debt$1.2B$27.0B$942.4B$9.4B$365.9B
Interest CoverageEBIT ÷ Interest expense-0.86x34.52x0.74x9.82x0.48x
NGVT leads this category, winning 4 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

JPM leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in JPM five years ago would be worth $21,820 today (with dividends reinvested), compared to $8,915 for NGVT. Over the past 12 months, NGVT leads with a +66.6% total return vs ECL's -1.0%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.6% vs NGVT's 10.1% — a key indicator of consistent wealth creation.

MetricNGVT logoNGVTIngevity Corporat…LIN logoLINLinde plcJPM logoJPMJPMorgan Chase & …ECL logoECLEcolab Inc.BAC logoBACBank of America C…
YTD ReturnYear-to-date+19.8%+22.8%-0.5%+1.3%+1.1%
1-Year ReturnPast 12 months+66.6%+12.6%+21.8%-1.0%+28.1%
3-Year ReturnCumulative with dividends+33.4%+49.4%+138.2%+52.4%+103.0%
5-Year ReturnCumulative with dividends-10.8%+89.1%+118.2%+29.8%+47.1%
10-Year ReturnCumulative with dividends+111.0%+402.9%+465.8%+139.1%+368.2%
CAGR (3Y)Annualised 3-year return+10.1%+14.3%+33.6%+15.1%+26.6%
JPM leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

LIN leads this category, winning 2 of 2 comparable metrics.

LIN is the less volatile stock with a 0.20 beta — it tends to amplify market swings less than NGVT's 1.27 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LIN currently trades 99.6% from its 52-week high vs ECL's 85.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricNGVT logoNGVTIngevity Corporat…LIN logoLINLinde plcJPM logoJPMJPMorgan Chase & …ECL logoECLEcolab Inc.BAC logoBACBank of America C…
Beta (5Y)Sensitivity to S&P 5001.27x0.20x0.94x0.63x0.86x
52-Week HighHighest price in past year$79.05$525.82$337.25$309.27$57.55
52-Week LowLowest price in past year$39.74$387.78$262.71$243.15$43.66
% of 52W HighCurrent price vs 52-week peak+91.1%+99.6%+95.1%+85.8%+97.3%
RSI (14)Momentum oscillator 0–10055.756.959.156.068.3
Avg Volume (50D)Average daily shares traded211K2.0M7.0M1.4M31.7M
LIN leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Evenly matched — ECL and BAC each lead in 1 of 2 comparable metrics.

Analyst consensus: NGVT as "Buy", LIN as "Buy", JPM as "Buy", ECL as "Buy", BAC as "Buy". Consensus price targets imply 23.2% upside for ECL (target: $327) vs 5.9% for JPM (target: $340). For income investors, BAC offers the higher dividend yield at 2.26% vs ECL's 1.00%.

MetricNGVT logoNGVTIngevity Corporat…LIN logoLINLinde plcJPM logoJPMJPMorgan Chase & …ECL logoECLEcolab Inc.BAC logoBACBank of America C…
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuyBuy
Price TargetConsensus 12-month target$76.67$562.14$339.75$326.91$61.13
# AnalystsCovering analysts1328613754
Dividend YieldAnnual dividend ÷ price+1.1%+1.9%+1.0%+2.3%
Dividend StreakConsecutive years of raises34153812
Dividend / ShareAnnual DPS$6.00$5.95$2.64$1.27
Buyback YieldShare repurchases ÷ mkt cap+2.2%+1.9%+3.9%+1.0%+5.1%
Evenly matched — ECL and BAC each lead in 1 of 2 comparable metrics.
Key Takeaway

LIN leads in 2 of 6 categories (Income & Cash Flow, Risk & Volatility). NGVT leads in 2 (Valuation Metrics, Profitability & Efficiency). 1 tied.

Best OverallIngevity Corporation (NGVT)Leads 2 of 6 categories
Loading custom metrics...

NGVT vs LIN vs JPM vs ECL vs BAC: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is NGVT or LIN or JPM or ECL or BAC a better buy right now?

For growth investors, JPMorgan Chase & Co.

(JPM) is the stronger pick with 3. 3% revenue growth year-over-year, versus -17. 0% for Ingevity Corporation (NGVT). Bank of America Corporation (BAC) offers the better valuation at 14. 7x trailing P/E (12. 6x forward), making it the more compelling value choice. Analysts rate Ingevity Corporation (NGVT) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — NGVT or LIN or JPM or ECL or BAC?

On trailing P/E, Bank of America Corporation (BAC) is the cheapest at 14.

7x versus Ecolab Inc. at 36. 5x. On forward P/E, Bank of America Corporation is actually cheaper at 12. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 0. 81x versus Linde plc's 1. 15x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — NGVT or LIN or JPM or ECL or BAC?

Over the past 5 years, JPMorgan Chase & Co.

(JPM) delivered a total return of +118. 2%, compared to -10. 8% for Ingevity Corporation (NGVT). Over 10 years, the gap is even starker: JPM returned +465. 8% versus NGVT's +111. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — NGVT or LIN or JPM or ECL or BAC?

By beta (market sensitivity over 5 years), Linde plc (LIN) is the lower-risk stock at 0.

20β versus Ingevity Corporation's 1. 27β — meaning NGVT is approximately 545% more volatile than LIN relative to the S&P 500. On balance sheet safety, Linde plc (LIN) carries a lower debt/equity ratio of 68% versus 42% for Ingevity Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — NGVT or LIN or JPM or ECL or BAC?

By revenue growth (latest reported year), JPMorgan Chase & Co.

(JPM) is pulling ahead at 3. 3% versus -17. 0% for Ingevity Corporation (NGVT). On earnings-per-share growth, the picture is similar: Ingevity Corporation grew EPS 61. 1% year-over-year, compared to -1. 2% for Ecolab Inc.. Over a 3-year CAGR, ECL leads at 4. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — NGVT or LIN or JPM or ECL or BAC?

JPMorgan Chase & Co.

(JPM) is the more profitable company, earning 20. 4% net margin versus -14. 3% for Ingevity Corporation — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LIN leads at 26. 3% versus 18. 1% for ECL. At the gross margin level — before operating expenses — JPM leads at 59. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is NGVT or LIN or JPM or ECL or BAC more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 0. 81x versus Linde plc's 1. 15x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Bank of America Corporation (BAC) trades at 12. 6x forward P/E versus 31. 9x for Ecolab Inc. — 19. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ECL: 23. 2% to $326. 91.

08

Which pays a better dividend — NGVT or LIN or JPM or ECL or BAC?

In this comparison, BAC (2.

3% yield), JPM (1. 9% yield), LIN (1. 1% yield), ECL (1. 0% yield) pay a dividend. NGVT does not pay a meaningful dividend and should not be held primarily for income.

09

Is NGVT or LIN or JPM or ECL or BAC better for a retirement portfolio?

For long-horizon retirement investors, Linde plc (LIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

20), 1. 1% yield, +402. 9% 10Y return). Both have compounded well over 10 years (LIN: +402. 9%, NGVT: +111. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between NGVT and LIN and JPM and ECL and BAC?

These companies operate in different sectors (NGVT (Basic Materials) and LIN (Basic Materials) and JPM (Financial Services) and ECL (Basic Materials) and BAC (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: NGVT is a small-cap quality compounder stock; LIN is a large-cap quality compounder stock; JPM is a large-cap deep-value stock; ECL is a mid-cap quality compounder stock; BAC is a large-cap deep-value stock. LIN, JPM, ECL, BAC pay a dividend while NGVT does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.